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OBJECTIVES: Economic evaluations (EE) are ubiquitous and growing in importance 
with increasing demand for healthcare services. However, healthcare decision 
makers often do not use this evidence when making decisions. Previous research 
has shown several factors influence the use of EE, such as credibility, complexity, 
and timeliness. However, no research has examined the relative importance of 
these factors in making EE more valuable as a service. This research shows what 
factors are most important to healthcare professionals/ administrators/research-
ers, when examining research using EE. METHODS: Study 1, an online question-
naire of Australian infection control practitioners (N= 35), sought ratings of the 
absolute and relative importance of a range of barriers and facilitators of using 
EE in healthcare decision making. Seven factors (rigor of the cost effectiveness 
analysis, quality of the clinical evidence, timeliness, communication, applicabil-
ity, conflicts of interest, equity) were selected from this study to inform Study 2. 
Study 2 used a discrete choice experiment (blocked, orthogonal design) to examine 
the relative importance of these seven factors in the choice between two health 
economists which differ in these attributes. This was administered online to a 
range of Australian healthcare decision makers. RESULTS: Study 1 showed that 
quality of clinical evidence was the most important factor when examining EE, 
followed by applicability, communication, and the rigour of the cost effectiveness 
analysis. Conflict of interest was the least important factor. Study 2 will demon-
strate the trade-offs between these factors. The results for this second study will 
be ready in March. CONCLUSIONS: This research shows which factors are most 
valuable for healthcare decision makers using EE. To our knowledge this is the 
first study to use a preference analytic technique to measure what is valuable in 
a decision tool. The findings from this research will provide guidance on how to 
better deliver EE to end users.
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OBJECTIVES: Public health policies rely largely on observational studies developed 
through the compilation of real world data. From the access and health technol-
ogy assessment (HTA) perspectives, real world data are an essential ancillary tool 
in decision-making, providing information on burden of disease, cost-of-illness, 
resource usage, treatment patterns, compliance, natural history of the disease, 
effectiveness and safety. The Brazilian Network for Health Technology Assessment 
(REBRATS) recommends the use of observational studies to develop economic 
evaluations for both effectiveness and safety data. However, the extent of use 
of such data in Brazil remains undetermined. Our objective was to identify the 
requirements and needs for epidemiological data regarding HTA submissions in 
Brazil. METHODS: We reviewed HTA requirements, reports and dossiers from the 
Brazilian HTA commission (CONITEC) for epidemiological data aimed at incor-
poration. Additionally, we searched Brazilian guidelines and regulations about 
principles for real world data requirements for HTA. RESULTS: CONITEC issued 
119 reports between the time of its establishment (April/2011) and the date of 
our analysis (December 08th, 2014). The Committee reported lack of real world 
studies in 11.8% of the submissions (14 of 119 reports), including the need of 
epidemiological studies (prevalence and incidence) (n= 8), safety and efficacy tri-
als (n= 3), safety study (n= 1), epidemiological and clinical characteristics studies 
(n= 1) and resource use and cost-of-illness analyses (n= 1). The lack of epidemio-
logic data was the most common issue (8 of 14 reports). However, real world data 
regarding safety, effectiveness and clinical characteristics were also critical (7 of 
14 reports). CONCLUSIONS: Our analysis showed that use of real world data in 
Brazil remains an unmet need for HTA.
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OBJECTIVES: Low cost generic programs (LCGPs) offer an affordable means to 
obtain medications which can be used to treat a myriad of acute and chronic 
conditions. However, since the medications are often purchased without using 
insurance, a claim will never be adjudicated. Thus, medication use may go unob-
served in administrative claims data, which are often used for research and quality 
control initiatives. This study sought to assess the characteristics and prevalence 
associated with LCGP use in the Medicare insured population. METHODS: Using 
data from the Medical Expenditure Panel Survey from 2006-2011, individuals 
were classified as LCGP users or non-users based on payment variables from 
pharmacy records. Demographics of users and non-users were compared includ-
ing age, gender, prescription drug coverage, and health-related characteristics. 
A multivariable logistic regression model was estimated to identify the charac-
teristics with the greatest association with use. RESULTS: With a total cohort of 
N= 9,906, 48.03% were classified as users. Half of the individuals with prescrip-
tion insurance coverage utilized these programs compared to nearly one-third 
of those without prescription coverage. The user group also used more medi-
cations per-person over the two-year period (77.20 vs 53.35, p< 0.01) and more 
unique medications (12.68 vs 8.71, p< 0.01). The user group also had higher 
average Charlson Comorbidity Index scores (1.75 vs 1.30, p< 0.01). In adjusted 
analyses, individuals with prescription insurance had 39% higher odds of using 
LCGPs. Each additional unique medication was associated with a 9% increase in 
the odds of being a user (OR 1.09, 95% CI 1.08 – 1.10). LCGP use was also associ-
ated with increasing income levels but not associated with increasing comor-
bidity scores. CONCLUSIONS: Nearly one-half of all Medicare insured persons 
used LCGPs during the study period. This may misrepresent exposure classifi-
cation when research or quality initiatives are based on administrative claims 
data.
materials for dissemination. METHODS: We surveyed HEOR professionals to gauge 
their perspective on the quality of HEOR communications materials. A 16-question 
on-line survey was sent to 300 HEOR professionals in July 2014. Descriptive analyses 
were conducted as appropriate. RESULTS: Fifty-nine surveys were returned fully or 
partially completed. Eighty-eight percent of respondents have advanced degrees, 
43% are employed by bio/pharma companies, 78% are HEOR directors or manag-
ers and 50% had more than 3 years in their current position. Forty-seven percent 
of respondents use internal medical writing teams and 62% subcontract writing to 
outside vendors. Dossiers are the most frequent item outsourced at 45%. Forty percent 
of respondents indicated that they outsource manuscripts and 25% of respondents 
outsource abstracts. Consistently across several quality measures, approximately 
55% of respondents are not satisfied with the quality of writing for their communi-
cation materials. Improvement in value messaging and methodology were the two 
most cited areas of concern about writing quality beyond the general question about 
satisfaction with overall writing quality. CONCLUSIONS: More than 50% of HEOR 
executive respondents seek better quality in written documents and more appropri-
ate terminology in addressing their business objectives with scientifically rigorous 
content. Therefore, it is apparent from these survey results that HEOR directors and 
managers consider nearly half of all their communications to not be well-written.
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OBJECTIVES: Effective communication of risk of medication side effects is neces-
sary in order to minimize its misinterpretation and over-estimation by patients. 
The study evaluated effect of communication style (verbal vs verbal + numeric) on 
perception of risk of experiencing medication side effects of different frequency and 
severity levels. METHODS: Participants were randomly presented with information 
on medication side effects using either verbal (e.g. ‘rarely’) or verbal + numeric (e.g. 
‘rarely i.e. 2 out of 100’) communication style for frequency descriptions, in a 2 (com-
munication style: verbal, verbal combined with numeric frequency) X 2 (side effect 
frequency: low, high) X 2 (side effect severity: mild, severe) experimental design. 
Perception of risk of experiencing side effects was measured and test for analysis 
of variance was performed. RESULTS: Communication style was observed to sig-
nificantly affect risk perception for certain combinations of severity and frequency. 
It was observed that with combined communication style (verbal + numeric), risk 
perception of severe side effects of low frequency decreased (mean difference: 11.24; 
C.L.: 4.60 – 17.82) whereas that of mild side effects of high frequency side increased 
(mean difference: 7.80; C.L.: 1.21 – 14.39) as compared to only verbal communication 
style. It was also observed that the low and high frequency side effects were better 
distinguished with respect to their risk when combined communication style was 
used (mean risk perception difference between low and high frequency side effects: 
36.24; C.L.: 31.58 – 40.89) as compared to verbal only (mean difference: 22.2; C.L.: 
17.53 – 26.84). Significant main effects of frequency and severity on risk perception 
were also observed. CONCLUSIONS: Use of numeric frequencies along with ver-
bal descriptions of risk of medication side effect helps in better understanding of 
underlying risk and reduces its over-estimation, especially for low frequency side 
effects. Healthcare professionals should take into consideration these effects while 
communicating side-effect risks to their patients.
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OBJECTIVES: In 2006 a number of studies were conducted in Kazakhstan with 
UNICEF, which have shown that the majority of children in children’s homes are at 
risk of essential nutrients deficiency. So we have investigated a nutrition adequacy 
according to the body needs of the orphans and children left without parental 
care in children’s homes of the health care system. METHODS: Were included 226 
children from national orphan homes in Akmola and Almaty regions in the ages 
of 6 to 36 months. The study did not include children with disabilities or severe 
diseases. 100 children (57 boys, 43 girls) from the families in organized groups 
were taken as control group. Were evaluated a physiological status, hemoglobin, 
morphofunctional status of the children, also the analysis of food packages and 
the chemical composition of the diet were done. Malnutrition was calculated by 
“Anthro” program (WHO, 2006). RESULTS: Birth weight corresponded to normal in 
67% of children under parental care and 33% of orphans, 56% of orphans are lag-
ging in teething development, in the control group was no lag (1%). 15% of orphans 
have clinical manifestations of changes in the skin, mucous membranes and bone. 
Consumption of the main types of products (primarily meat, milk, fish, vegetables 
and fruit) in children’s homes was below current standards and recommendations 
of the Kazakh Academy of Nutrition, based on international experience. Because of 
inadequate food intake, the orphans have an expressed protein deficit (25%), PUFAs 
(32%), vitamin A (44%), pyridoxine (45%), pantothenic acid (53%), vitamin B12 (37 %), 
ascorbic acid (59%) and copper. CONCLUSIONS: Analysis showed that the actual 
children nutrition scheme is obsolete and needs to be revised in a short time. The 
study will have indices of more in-depth clinical examination and QoL evaluation 
with further economical calculation (budget impact, etc.)
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